Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001673232-25-000012

PRESIDENT AND COO sold 22,500 shares at $470.43 ($10,584,756)

  • PRESIDENT AND COO acquired 22,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BENKOWITZ MICHAEL · PRESIDENT AND COO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-17 Exercise or conversion : show line 1 in the form 10b5-1 +14,625 $135.42 $1,980,518 14,625 I
2025-11-17 Sale : show line 2 in the form 10b5-1 −14,625 $470.43 $6,880,091 0 I
2025-11-17 Exercise or conversion : show line 3 in the form 10b5-1 +2,625 $146.03 $383,329 2,625 I
2025-11-17 Exercise or conversion : show line 4 in the form 10b5-1 +5,250 $146.03 $766,658 7,875 I
2025-11-17 Sale : show line 5 in the form 10b5-1 −7,875 $470.43 $3,704,665 0 I
Open-market sales · 22,500 sh · avg $470.43 · $10,584,756

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-11-17 Exercise or conversion : show line 6 in the form 10b5-1 Stock Options −14,625 $135.42 2026-03-15 14,625 12,000 I
2025-11-17 Exercise or conversion : show line 7 in the form 10b5-1 Stock Options −2,625 $146.03 2026-03-15 2,625 0 I
2025-11-17 Exercise or conversion : show line 8 in the form 10b5-1 Stock Options −5,250 $146.03 2026-03-15 5,250 37,690 I
Loading xslF345X05/primarydocument.xml…